These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11197804)

  • 21. [Hyperamylasemia in systemic lupus erythematosus (SLE)].
    Kurosawa M; Terashima K; Nishimaki T; Morito T; Kasukawa R
    Ryumachi; 1988 Feb; 28(1):14-9. PubMed ID: 2455355
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoantibodies--what do they recognize?
    Tan EM
    Verh Dtsch Ges Pathol; 1996; 80():1-11. PubMed ID: 9020568
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to new cytoplasmic autoantigens: anti-JA, a potential marker for disease activity in systemic lupus erythematosus.
    Bonfa E; Tavares AV; Viana VS; Levy-Neto M; Kumeda CA; Cossermelli W
    Braz J Med Biol Res; 1992; 25(6):601-9. PubMed ID: 1342236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of systemic lupus erythematosus associated with persistent p-type hyperamylasemia during steroid therapy (author's transl)].
    Yoshida H; Ueda M; Fujii N; Akamatsu K; Tsunashima T
    Nihon Shokakibyo Gakkai Zasshi; 1976 Dec; 73(12):1599-605. PubMed ID: 1035331
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M; Husz S; Dobozy A
    Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia.
    Hara A; Furuichi K; Higuchi M; Iwata Y; Sakai N; Kaneko S; Wada T
    Br J Haematol; 2013 Jan; 160(2):244-50. PubMed ID: 23151030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):927-47. PubMed ID: 22026362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Schulman S; Langevitz P; Livneh A; Mortinowitz U; Seligsohn U; Varon D
    Thromb Haemost; 1996 Sep; 76(3):344-6. PubMed ID: 8883268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolipasemia and celiac disease.
    Garcia-Gonzalez M; Defarges-Pons V; Monescillo A; Hernandez F; Cano-Ruiz A
    Am J Gastroenterol; 1995 Dec; 90(12):2233-4. PubMed ID: 8540526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of macroamylasemia due to IgA, K globulin-bound amylase (author's transl)].
    Uesugi S; Higuchi Y; Kanemitsu F; Taketa K; Shimamura J; Kobayashi M
    Nihon Shokakibyo Gakkai Zasshi; 1979 Jan; 76(1):139-45. PubMed ID: 106147
    [No Abstract]   [Full Text] [Related]  

  • 32. [Macroamylasemia. Immunoglobulin a-amylase-complexes as rare cause of hyperamylasemia (author's transl)].
    Bohner J; Stein W; Dilger J
    Klin Wochenschr; 1980 Apr; 58(8):403-7. PubMed ID: 6156270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
    Nagel J; Saxne T; Geborek P; Bengtsson AA; Jacobsen S; Svaerke Joergensen C; Nilsson JÅ; Skattum L; Jönsen A; Kapetanovic MC
    Lupus; 2017 Sep; 26(10):1072-1081. PubMed ID: 28420056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Existence of IgA-antiprothrombin antibody in a patient with systemic lupus erythematosus.
    Matsuda J; Sanaka T; Yoshida M; Gotoh M; Gohchi K
    Eur J Haematol; 2002 Aug; 69(2):126-7. PubMed ID: 12366720
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy.
    Nagasawa J; Kurasawa K; Maezawa R; Owada T; Hanaoka R; Fukuda T
    Lupus; 2013 Sep; 22(10):1060-3. PubMed ID: 23886640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamides.
    Schorlemmer HU; Bartlett RR
    Transplant Proc; 1998 Dec; 30(8):4153-5. PubMed ID: 9865331
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolactin and IgG-prolactin complex levels in patients with rheumatic arthritis.
    Leiderman S; Gurfinkiel M; Damilano S; Lago RA; Martins S; Rosman F; Hamaui A; Maccagno A
    Ann N Y Acad Sci; 2002 Jun; 966():252-7. PubMed ID: 12114280
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.
    Marchalonis JJ; Schluter SF; Wilson L; Yocum DE; Boyer JT; Kay MM
    Gerontology; 1993; 39(2):65-79. PubMed ID: 8514202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).
    Kasatkar P; Ghosh K; Shetty S
    Ann Hematol; 2014 Jan; 93(1):173-5. PubMed ID: 23625134
    [No Abstract]   [Full Text] [Related]  

  • 40. Reactivity of autoantibodies and DNA/anti-DNA complexes with a novel 110-kilodalton phosphoprotein in systemic lupus erythematosus and other diseases.
    Minota S; Jarjour WN; Roubey RA; Mimura T; Winfield JB
    J Immunol; 1990 Feb; 144(4):1263-9. PubMed ID: 1689348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.